The study investigates how metabolic syndrome components relate to cognitive problems in schizophrenia patients.
The research involved 133 patients and used the BACS test for cognitive assessment while following International Diabetes Federation criteria for metabolic syndrome.
Findings indicate that hyperglycemia negatively impacts verbal fluency and attention, while abdominal obesity is linked to reduced executive functions, suggesting that treating these metabolic issues could improve cognitive abilities in these patients.